This is primarily supported by the clinical efficacy of TNF blocking agents in the treatment of RA but also by the fact that overexpression of TNF is sufficient to cause inflammatory arthritis in mice [3-7]. The gene discussed is TNF; the disease is rheumatoid arthritis.